Michael Ph.D.

Principal Scientist at TCR2 Therapeutics - Cambridge, MA, US

Michael Ph.D.'s Colleagues at TCR2 Therapeutics
Peter Olagunju

Chief Technology Officer

Contact Peter Olagunju

Stan Russell

Vice President | Quality

Contact Stan Russell

Holly Horton

Senior Director of Pharmacology

Contact Holly Horton

Kevin Rees

Sr. Manager, Talent Acquisition

Contact Kevin Rees

Shawn Moran

Laboratory Operations Manager

Contact Shawn Moran

View All Michael Ph.D.'s Colleagues
Michael Ph.D.'s Contact Details
HQ
617-949-5200
Location
Company
TCR2 Therapeutics
Michael Ph.D.'s Company Details
TCR2 Therapeutics logo, TCR2 Therapeutics contact details

TCR2 Therapeutics

Cambridge, MA, US • 250 - 499 Employees
BioTech/Drugs

TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.

Cancer therapy T cell biology Immunology Molecular biology Biotech Biotech
Details about TCR2 Therapeutics
Frequently Asked Questions about Michael Ph.D.
Michael Ph.D. currently works for TCR2 Therapeutics Inc.
Michael Ph.D.'s role at TCR2 Therapeutics Inc is Principal Scientist.
Michael Ph.D.'s email address is ***@tcr2.com. To view Michael Ph.D.'s full email address, please signup to ConnectPlex.
Michael Ph.D. works in the Biotechnology industry.
Michael Ph.D.'s colleagues at TCR2 Therapeutics are Robert Hofmeister, Peter Olagunju, Stan Russell, Holly Horton, Kevin Rees, Shawn Moran, Lindsay Webb and others.
Michael Ph.D.'s phone number is 617-949-5200
See more information about Michael Ph.D.